Platelet count response to Helicobacter pylori eradication in Iranian patients with idiopathic thrombocytopenic purpura

Mediterranean Journal of Hematology and Infectious Diseases

Volumn 4, Issue 1, 2012, Pages

  Payandeh, Mehrdad ^a,b   Sohrabi, Nasrollah ^a   Zare, Mohammad Erfan ^a,b   Kansestani, Atefeh Nasir ^a,b   Hashemian, Amir Hossein ^a  

^a KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; BACTERIUM ANTIBODY; CLARITHROMYCIN; PROTON PUMP INHIBITOR;

ADOLESCENT; ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ERADICATION THERAPY; FEMALE; HELICOBACTER INFECTION; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INFECTION CONTROL; IRAN; MALE; OUTCOME ASSESSMENT; PREVALENCE; RETROSPECTIVE STUDY; THROMBOCYTE COUNT; TREATMENT RESPONSE; UREA BREATH TEST;

EID: 84875970231     PISSN: None     EISSN: 20353006     Source Type: Journal    
DOI: 10.4084/MJHID.2012.056     Document Type: Article

References (29)

1. Correa P, Piazuelo MB. Natural history of Helicobacter pylori infection. Dig Liver Dis 2008; 40: 490-6. http://dx.doi.org/10.1016/j.dld.2008.02.035 PMid:18396115 PMCid:3142999
2. Menaker RJ, Sharaf AA, Jones NL. Helicobacter pylori infection and gastric cancer: host, bug, environment, or all three? Curr Gastroenterol Rep 2004; 6(6):429-35. http://dx.doi.org/10.1007/s11894-004-0063-9 PMid:15527671
3. Graham DY, Kimura K, Shimoyama T, Takemoto T. Helicobacter pylori infection in Japan: current status and future options. Eur J Gastroenterol Hepatol 1994; (6 Suppl 1):S1-4.
4. Yim JY, Kim N, Choi SH, Kim YS, Cho KR, Kim SS, Seo GS, Kim HU, Baik GH, Sin CS, Cho SH, Oh BH. Seroprevalence of Helicobacter pylori in South Korea. Helicobacter 2007; 12:333-40. http://dx.doi.org/10.1111/j.1523-5378.2007.00504.x PMid:17669107
5. Abadi AT, Taghvaei T, Mobarez AM, Carpenter BM, Merrell DS. Frequency of antibiotic resistance in Helicobacter pylori strains isolated from the northern population of Iran. J Microbiol 2011; 49(6):987-93. http://dx.doi.org/10.1007/s12275-011-1170-6 PMid:22203563 PMCid:3275342
6. Graham DY, Malaty HM, Evans DG, Evans DJ Jr, Klein PD, Adam E. Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Effect of age, race, and socioeconomic status. Gastroenterology 1991; 100:1495-501. PMid:2019355
7. Hershko C, Ianculovich M, Souroujon M. A hematologist's view of unexplained iron deficiency anemia in males: Impact of Helicobacter pylori eradication. Blood Cells Mol Dis 2007; 38(1):45-53. http://dx.doi.org/10.1016/j.bcmd.2006.09.006 PMid:17067833
8. Annibale B, Lahner E, Bordi C, Martino G, Caruana P, Grossi C, Negrini R, Delle Fave G. Role of Helicobacter pylori infection in pernicious anaemia. Dig Liver Dis 2000; 32(9):756-62. http://dx.doi.org/10.1016/S1590-8658(00)80351-5
9. Gasbarrini A, Franceschi F, Tartaglione R, Landolfi R, Pola P, Gasbarrini G. Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori. Lancet 1998; 352:878. http://dx.doi.org/10.1016/S0140-6736(05)60004-9
10. Hohmann AW, Booth K, Peters V, Gordon DL, Comacchio RM. Common epitope on HIV p24 and human platelets. Lancet 1993; 342:1274-5. http://dx.doi.org/10.1016/0140-6736(93)92363-X
11. Romero R, Kleinman RE. Thrombocytopenia associated with acute hepatitis B infection. Pediatrics 1993; 91:150-2. PMid:8416484
12. Nagamine T, Ohtuka T, Takehara K, Arai T, Takagi H, Mori M. Thrombocytopenia associated with hepatitis C viral infection. J Hepatol 1996; 24:135-40. http://dx.doi.org/10.1016/S0168-8278(96)80021-3
13. Franceschi F, Christodoulides N, Kroll MH, Genta RM. Helicobacter pylori and idiopathic thrombocytopenic purpura. Ann Intern Med 2004; 140:766-7. PMid:15126268
14. Takahashi T, Yujiri T, Shinohara K, Inoue Y, Sato Y, Fujii Y, Okubo M, Zaitsu Y, Ariyoshi K, Nakamura Y, Nawata R, Oka Y, Shirai M, Tanizawa Y. Molecular mimicry by Helicobacter pylori CagA protein may be involved in the pathogenesis of H pyloriassociated chronic idiopathic thrombocytopenic purpura. Br J Haematol 2004; 124:91-6. http://dx.doi.org/10.1046/U365-2141.2003.04735.x PMid:14675413
15. Tag HS, Lee HS, Jung SH, Kim BK, Kim SB, Lee A, Lee JS, Shin SH, Kim YS. Effects of Helicobacter pylori eradication in patients with immune thrombocytopenic purpura. Korean J Hematol 2010; 45(2):127-32.
16. Emilia G, Luppi M, Zucchini P, Morselli M, Potenza L, Forghieri F, Volzone F, Jovic G, Leonardi G, Donelli A, Torelli G. Helicobacter pylori infection and chronic immune thrombocytopenic purpura: long-term results of bacterium eradication and association with bacterium virulence profiles. Blood 2007; 110:3833-41. http://dx.doi.org/10.1182/blood-2006-12-063222 PMid: 17652264
17. Inaba T, Mizuno M, Take S, Suwaki K, Honda T, Kawai K, Fujita M, Tamura T, Yokota K, Oguma K, Okada H, Shiratori Y. Eradication of Helicobacter pylori increases platelet count in patients with idiopathic thrombocytopenic purpura in Japan. Eur J Clin Invest 2005; 35:214-219. http://dx.doi.org/10.1111/U365-2362.2005.01471.x PMid:15733077
18. Fujimura K, Kuwana M, Kurata Y, Imamura M, Harada H, Sakamaki H, Teramura M, Koda K, Nomura S, Sugihara S, Shimomura T, Fujimoto TT, Oyashiki K, Ikeda Y. Is eradication therapy useful as the first line of treatment in Helicobacter pylori positive idiopathic thrombocytopenic purpura? Analysis of 207 eradicated chronic ITP cases in Japan. Int J Hematol 2005; 81:162168. http://dx.doi.org/10.1532/IJH97.04146 PMid:15765787
19. Ahn ER, Tiede MP, Jy W, Bidot CJ, Fontana V, Ahn YS. Platelet activation in Helicobacter pylori-associated idiopathic thrombocytopenic purpura: eradication reduces platelet activation but seldom improves platelet counts. Acta Haematol 2006; 116:1924. http://dx.doi.org/10.1159/000092343 PMid:16809885
20. Stasi R, Rossi Z, Stipa E, Amadori S, Newland AC, Provan D. Helicobacter pylori eradication in the management of patients with idiopathic thrombocytopenic purpura. Am J Med 2005; 118:414-9. http://dx.doi.org/10.1016/i.amimed.2004.09.014 PMid:15808140
21. Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold DM, Bussel JB, Cines DB, Chong BH, Cooper N, Godeau B, Lechner K, Mazzucconi MG, McMillan R, Sanz MA, Imbach P, Blanchette V, Kühne T, Ruggeri M, George JN. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood 2009; 113(11):2386-93. http://dx,10.1182/blood-2008-07-162503
22. Jackson SC, Beck P, Buret AG, O'Connor PM, Meddings J, Pineo G, Poon MC. Long term platelet responses to Helicobacter pylori eradication in Canadian patients with immune thrombocytopenic purpura. Int J Hematol 2008; 88(2):212-8. http://dx.doi.org/10.1007/s12185-008-0138-8 PMid:18668306
23. Logan RP, Walker MM. ABC of the upper gastrointestinal tract:Epidemiology and diagnosis of Helicobacter pylori infection. Bmj 2001; 323:920-922. http://dx.doi.org/10.1136/bmj.323.7318.920 PMid:11668141 PMCid:1121445
24. Malfertheiner P, Megraud F, O'Morain C, Bazzoli F, El-Omar E, Graham D, Hunt R, Rokkas T, Vakil N, Kuipers EJ. Current concepts in the management of Helicobacter pylori infection -The Maastricht III Consensus Report. Gut 2007; 56:772-81. http://dx.doi.org/10.1136/gut.2006.101634 PMid:17170018 PMCid:1954853
25. Michel M, Cooper N, Jean C, Frissora C, Bussel JB. Does Helicobacter pylorus initiate or perpetuate immune thrombocytopenic purpura? Blood 2004; 103:890-6. http://dx.doi.org/10.1182/blood-2003-03-0900 PMid:12920031
26. Kodama M, Kitadai Y, Ito M, Kai H, Masuda H, Tanaka S, Yoshihara M, Fujimura K, Chayama K. Immune response to CagA protein is associated with improved platelet count after Helicobacter pylori eradication in patients with idiopathic thrombocytopenic purpura. Helicobacter 2007; 12(1):36-42. http://dx.doi.org/10.1111/j.1523-5378.2007.00477.x PMid:17241299
27. Kim JW, Kim JG, Chae SL, Cha YJ, Park SM. High prevalence of multiple strain colonization of Helicobacter pylori in Korean patients: DNA diversity among clinical isolates from the gastric corpus, antrum and duodenum. Korean J Intern Med 2004; 19(1): 19. PMid:15053036
28. Molaei M, Foroughi F, Mashayekhi R, Haghazali M, Zojaji H, Jafari F, Dabiri H, Zali MR. CagA status and VacA subtypes of Helicobacter pylori in relation to histopathologic findings in Iranian population. Indian J Pathol Microbiol 2010; 53(1):24-7. http://dx.doi.org/10.4103/0377-4929.59178 PMid:20090217
29. Pérez-Pérez GI, Bhat N, Gaensbauer J, Fraser A, Taylor DN, Kuipers EJ, Zhang L, You WC, Blaser MJ. Country-specific constancy by age in CagA+ proportion of Helicobacter pylori infections. Int J Cancer 1997; 72:453-456. http://dx.doi.org/10.1002/(SICI)1097-0215(19970729)72:3<453::AID-IJC13>3.0.CQ;2-D